Pressure BioSciences’ BaroFold Technology Achieves Pivotal Equipment Sale and Begins Scale-up in Service to Leading Global Contract Devt. & Mfg. Organization

2 years ago

Patented BaroFold Platform is Critical Enabler for Biopharma Manufacturing and Quality Assurance;Company Believes Future BaroFold Equipment and Recurring Utilization/Support FeesShould…

Novo Integrated Sciences Provides Update on Potential Share Repurchase Program

2 years ago

BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today provides an update with respect to…

CENTR Launches Enhanced Gut Health and Cognitive Performance Drinks on Amazon.com

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - September 8, 2023) - CENTR Brands Corp. (CSE: CNTR)  (FSE: 303) (OTCQB: CNTRF) ("CENTR" or…

New Company, Integrated RCM Services, to Provide Third-Party Billing for Behavioral Health Providers

2 years ago

HAINESPORT, NJ / ACCESSWIRE / September 8, 2023 / The process of insurance billing, utilization review, appeals, and payment can…

Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test

2 years ago

New assays for ketamine and tramadol testing pass initial Intelligent Fingerprinting design phase and begin next stage of transfer to…

Parion Sciences Announces Publication of Phase 2 CLEAN-PCD Study in The Lancet Respiratory Medicine

2 years ago

Published Phase 2 Study findings demonstrate safety and efficacy of idrevloride in hypertonic saline for treatment of primary ciliary dyskinesiaAbstract…

WW International, Inc. Announces Participation in Upcoming Investor Conferences

2 years ago

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced…

BioRestorative Therapies Announces Activation of Northwell Health in the Company’s Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease

2 years ago

--Site activation allows for patients in the State of New York to participate in the BRTX-100 trial— --15 Clinical Sites…

CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology

2 years ago

BERKELEY HEIGHTS, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…

Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquisition Strategy Differentiates Company in Projected $51B Global Cannabis Market

2 years ago

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- via IBN — Lucy Scientific Discovery Inc. (NASDAQ: LSDI) today announces its placement in…